Globus Medical buys NuVasive in all-stock for $3.1 billion
Globus Medical, a US-based publicly traded medical device company making products to treat musculoskeletal disorders, acquired NuVasive in an all-stock deal worth $3.1.
Drugs
Medical
Pharma
Climate
Health
Medical
Turkey, Syria quake toll crosses 20,000, global agencies call for new aid routes
About 14 trucks carrying relief materials reached opposition-held areas in Syria from Turkey, through the only authorized route for aid deliveries to quake-struck.
Health
Medical
WHO boss Tedros wants to ‘banish’ trans fats
Nine of the 16 countries with the highest estimated proportion of coronary heart disease deaths caused by trans fat still do not have.
Climate
Medical
Global leaders lack long-term vision on climate action, nuclear threats: UN chief says
Global politicians and decision-makers lack a long-term vision on climate action, financing debt of lower-income nations, cultural rights and rising nuclear threats, the.
Drugs
Medical
Pharma
Blood cancer therapy may help to treat ovarian cancer: Swedish scientists
A cell therapy currently used to treat blood cancers can lead to clinical studies for ovarian cancer, scientists from one of the world’s.
Drugs
Medical
Pharma
GSK Plc gets FDA nod to make oral drug for anaemic CKD patients
GSK Plc., a British global pharmaceutical company, announced the FDA had approved an oral drug to treat anaemia arising from chronic kidney disease.
Drugs
Medical
Pharma
Max Healthcare profit jumps 7%, to raise INR 42 billion in debt
Max Healthcare, one of India’s largest private hospital chains, reported a 7% rise in profit after tax, on revenue of INR 15.6 billion,.
Health
Medical
Pharma
Junk food increase ovarian, brain cancer risk: UK study
Fizzy drinks, mass-produced breads, many ready meals, and most breakfast cereals increase the risk of cancer as they contain higher salt, fat, sugar.
Drugs
Medical
Pharma
12 African nations commit to end AIDS in children by 2030
Twelve African nations have drawn out a blueprint to stop AIDS in children by 2030, a move welcomed by the United Nations.
Drugs
Medical
Pharma
China’s lifting of COVID-19 curbs to ease supply chain disruptions: Glenmark
Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may.